Literature DB >> 9971781

ATP depletion blocks herpes simplex virus DNA packaging and capsid maturation.

A Dasgupta1, D W Wilson.   

Abstract

During herpes simplex virus (HSV) assembly, immature procapsids must expel their internal scaffold proteins, transform their outer shell to form mature polyhedrons, and become packaged with the viral double-stranded (ds) DNA genome. A large number of virally encoded proteins are required for successful completion of these events, but their molecular roles are poorly understood. By analogy with the dsDNA bacteriophage we reasoned that HSV DNA packaging might be an ATP-requiring process and tested this hypothesis by adding an ATP depletion cocktail to cells accumulating unpackaged procapsids due to the presence of a temperature-sensitive lesion in the HSV maturational protease UL26. Following return to permissive temperature, HSV capsids were found to be unable to package DNA, suggesting that this process is indeed ATP dependent. Surprisingly, however, the display of epitopes indicative of capsid maturation was also inhibited. We conclude that either formation of these epitopes directly requires ATP or capsid maturation is normally arrested by a proofreading mechanism until DNA packaging has been successfully completed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9971781      PMCID: PMC104443     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Identification of genes encoding two capsid proteins (VP24 and VP26) of herpes simplex virus type 1.

Authors:  M D Davison; F J Rixon; A J Davison
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

2.  Sequence analysis of the splice junction in the transcript of herpes simplex virus type 1 gene UL15.

Authors:  A Dolan; M Arbuckle; D J McGeoch
Journal:  Virus Res       Date:  1991-06       Impact factor: 3.303

3.  The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate.

Authors:  F Y Liu; B Roizman
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  The herpes simplex virus UL33 gene product is required for the assembly of full capsids.

Authors:  M F al-Kobaisi; F J Rixon; I McDougall; V G Preston
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

5.  Processing of the herpes simplex virus assembly protein ICP35 near its carboxy terminal end requires the product of the whole of the UL26 reading frame.

Authors:  V G Preston; F J Rixon; I M McDougall; M McGregor; M F al Kobaisi
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

6.  Channel catfish virus: a new type of herpesvirus.

Authors:  A J Davison
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

7.  Use of Ar+ plasma etching to localize structural proteins in the capsid of herpes simplex virus type 1.

Authors:  W W Newcomb; J C Brown
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Structure of the herpes simplex virus capsid: effects of extraction with guanidine hydrochloride and partial reconstitution of extracted capsids.

Authors:  W W Newcomb; J C Brown
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Distinct monoclonal antibodies separately label the hexons or the pentons of herpes simplex virus capsid.

Authors:  B L Trus; W W Newcomb; F P Booy; J C Brown; A C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

10.  Differentiation of multiple domains in the herpes simplex virus 1 protease encoded by the UL26 gene.

Authors:  F Liu; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

View more
  25 in total

1.  Packaging-competent capsids of a herpes simplex virus temperature-sensitive mutant have properties similar to those of in vitro-assembled procapsids.

Authors:  F J Rixon; D McNab
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  ATP-Dependent localization of the herpes simplex virus capsid protein VP26 to sites of procapsid maturation.

Authors:  J H Chi; D W Wilson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  ATP is required for correct folding and disulfide bond formation of rotavirus VP7.

Authors:  A Mirazimi; L Svensson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.

Authors:  M Tritel; M D Resh
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  pH reduction as a trigger for dissociation of herpes simplex virus type 1 scaffolds.

Authors:  David A McClelland; James D Aitken; David Bhella; David McNab; Joyce Mitchell; Sharon M Kelly; Nicholas C Price; Frazer J Rixon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Reconstitution of herpes simplex virus type 1 nuclear capsid egress in vitro.

Authors:  Gaudeline Rémillard-Labrosse; Ginette Guay; Roger Lippé
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Role of the UL25 protein in herpes simplex virus DNA encapsidation.

Authors:  Shelley K Cockrell; Minerva E Sanchez; Angela Erazo; Fred L Homa
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

8.  Eclipse phase of herpes simplex virus type 1 infection: Efficient dynein-mediated capsid transport without the small capsid protein VP26.

Authors:  Katinka Döhner; Kerstin Radtke; Simone Schmidt; Beate Sodeik
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

9.  A mutation in UL15 of herpes simplex virus 1 that reduces packaging of cleaved genomes.

Authors:  Kui Yang; Elizabeth G Wills; Joel D Baines
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

10.  The antiapoptotic herpes simplex virus glycoprotein J localizes to multiple cellular organelles and induces reactive oxygen species formation.

Authors:  Martine Aubert; Zheng Chen; Robin Lang; Chung H Dang; Carla Fowler; Derek D Sloan; Keith R Jerome
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.